New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Author :
By Franco Muggia, MD
Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.
Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.
https://www.asia.elsevierhealth.com/new-drugs-for-malignancy-an-issue-of-hematologyoncology-clinics-of-north-america-9781455738762.html300027New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9781455738762_8.jpg74.2498.99USDInStock/Clinics/Medicine & Surgery/Hematology/Medicine/Hematology/Clinics/Clinics/Medicine/Hematology/Japan Titles43887254431214505462250546665255041525991152631601418269243350884886536505455351451205259833Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways. Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.00add-to-cart97814557387622012ProfessionalBy Franco Muggia, MD20121Book152w x 229h (6.00" x 9.00")Saunders1440May 8, 2012IN STOCKBy <STRONG>Franco Muggia</STRONG>, MDClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
